Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

计划入组 108 人 · 首次发布于 2025 年 12 月 15 日

Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma

计划入组 13 人 · 首次发布于 2019 年 1 月 15 日

Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

计划入组 82 人 · 首次发布于 2018 年 4 月 10 日

NANT Squamous Cell Carcinoma Vaccine

GPR87 antagonists (squamous cell carcinoma)

NUCC-0227383

Gamida Cell

Israel

GAMIDA CELL INC.

United States

CELL GENESYS INC.

United States

MD Anderson Research Highlights: Modified NRF2 Activator, Canakinumab in MDS, and More

MD Anderson Highlights: Modified NRF2 Activator Reverses Chronic Pain, Canakinumab Shows Promise in MDS Subgroup

Insilico Medicine Uses AI to Map Molecular Landscape and Identify Therapeutic Targets for Rare Sinonasal Cancer